Investing News NetworkDecember 09, 2024Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles HealthDownload the PDF here.cov-auasx-covCOV:AU
Investing News Network21 May 2024 Cleo Diagnostics Revolutionising Ovarian Cancer Diagnosis Through Accurate and Early Detection Revolutionising Ovarian Cancer Diagnosis Through Accurate and Early Detection Keep Reading...
Investing News Network17 March 2025 CLEO Delivers Commercial Development Milestone Cleo Diagnostics (COV:AU) has announced CLEO Delivers Commercial Development MilestoneDownload the PDF here. Keep Reading...
Investing News Network27 February 2025 Appendix 4D and Half Yearly Accounts Cleo Diagnostics (COV:AU) has announced Appendix 4D and Half Yearly AccountsDownload the PDF here. Keep Reading...
Investing News Network31 January 2025 Quarterly activities and cashflow report Cleo Diagnostics (COV:AU) has announced Quarterly activities and cashflow reportDownload the PDF here. Keep Reading...
Investing News Network26 November 2024 The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial Cleo Diagnostics (COV:AU) has announced The Royal Women's Hospital Joins CLEO Ovarian Cancer TrialDownload the PDF here. Keep Reading...
Locksley Resources' Underground Mapping Reveals Major New Target Boosting High-Grade Antimony Potential at its Mojave Project Desert Antimony Mine 11h
precious-metals-investing Earthwise Minerals Completes Private Placement and Makes Changes to the Management Team 5h
precious-metals-investing Locksley Resources' Underground Mapping Reveals Major New Target Boosting High-Grade Antimony Potential at its Mojave Project Desert Antimony Mine 11h
base-metals-investing Tartisan Nickel Corp. Acquires Additional Nickel-Copper Claims at Turtle Pond, Northwestern Ontario 14h